J Clin Pathol Qual Control.  2001 Jun;23(1):145-155.

Annual Report on External Quality Assessment in Therapeutic Drug Monitoring in Korea (2000)

• Kim JQ
• Kwon OH
• Kwon HJ
• Kim YK
• Kim JW
• Kim TJ
• Park IJ
• Song J
• Lee KN
• Jung YS

Abstract

Two trials of external quality assessment for Therapeutic Drung Monitoring (TDM) were performed in 2000. A total of two specimens were distributed. One specimen was distributed to 82 laboratories with 75 repsonse (91.4%) in the first trial and the other specimen to 82 laboratories with 71 response (86.6%) in the second trial. In first trial, 26 test items including acetaminophen, amikacin, amitriptyline, carbamazepine, chloramphenicol, cyclosporine, digoxin, disopyramide, ethosuximide, free phenytoin, gentamicin, lidocaine, lithium, methotrexate, N-acetyl-procainamide, phenobarbital, phenytoin, primidone, procainamide, propranolol, quinidine, salicylate, theophylline, tobramycin, valproic acid and vancomycin were evaluated. In second trial, 17 items excluding amitriptyline, chloramphenicol, cyclosporine, disopyramide, free phenytoin, lidocaine, lithium, methotrexate and propranolol were evaluated. The results of two trials in 2000 were summarized as follows.

MeSH Terms

Acetaminophen
Amikacin
Amitriptyline
Carbamazepine
Chloramphenicol
Cyclosporine
Digoxin
Disopyramide
Drug Monitoring*
Ethosuximide
Gentamicins
Korea*
Lidocaine
Lithium
Methotrexate
Phenobarbital
Phenytoin
Primidone
Procainamide
Propranolol
Quinidine
Theophylline
Tobramycin
Valproic Acid
Vancomycin
Acetaminophen
Amikacin
Amitriptyline
Carbamazepine
Chloramphenicol
Cyclosporine
Digoxin
Disopyramide
Ethosuximide
Gentamicins
Lidocaine
Lithium
Methotrexate
Phenobarbital
Phenytoin
Primidone
Procainamide
Propranolol
Quinidine
Theophylline
Tobramycin
Valproic Acid
Vancomycin